The return of the long-extinct wooly mammoth or dodo bird may sound like a storyline straight out of science fiction. It’s not. Several de-extinction projects all share an ambitious aim to resurrect ...
Despite the regulatory and funding roadblocks, Murray and fellow researcher Elizabeth Maga continue to work on a line of genetically engineered goats, which carry a human gene that produces elevated ...
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
Funding will accelerate the development of breakthrough genetic tools and technologies including software, wetware, and artificial wombs to advance species preservation and restoration as well as ...
The victims of extinction are countless and their killers numerous—but, in recent centuries, there’s been one obvious, enduring culprit: Homo sapiens. As humankind has increased in numbers and ...
As data management platforms go, the one developed by Colossal Biosciences stands in its own large petri dish as both innovative and out of the ordinary. After all, how many software tools help ...
Three genetically engineered wolves that may resemble extinct dire wolves are trotting, sleeping and howling in an undisclosed secure location in the U.S., according to the company that aims to bring ...
Over millennia, there has been a seamless continuum of technologies for genetic modification of plants, animals, and microorganisms, with progressive improvements in precision and predictability – a ...
Transgenic organisms are living beings whose genetic material has been artificially modified by introducing genes from another species. This process, known as transgenesis, allows for the transfer of ...
Over the past century, worldwide consumption of food-animal products such as meat, milk, and eggs has steadily grown due to increases in global population and per capita income that fuel demand for ...
Colossal Secures $60M Series A Funding To Advance Genetic Engineering and De-extinction Technologies
DALLAS--(BUSINESS WIRE)--Colossal Biosciences, a breakthrough biosciences and genetic engineering company, announced an oversubscribed $60M Series A financing led by Thomas Tull and At One Ventures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results